ARCT News and Press, Arcturus Therapeutics Ltd. From 09/10/21

The company has a specific opportunity to be a vaccine supplier within Asia and to the world. Re-instated trials are proceeding after disappointment earlier in the year. As a well-capitalised company, there should be no shareholder risk dilution for a couple of years. Company ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips In 2020, the race for the Covid-19 vaccine distorted investment inflows in the biotechnology sector. Back then, emerging biotech stocks tripled or more on hopes that they would come out with a vaccine. Buying interest in ...

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare d...

Gainers: Fulcrum Therapeutics (NASDAQ:FULC) +123%. Lightning eMotors (NYSE:ZEV) +52%. 3D Systems (NYSE:DDD) +41%. MediaCo (NASDAQ:MDIA) +40%. Allied Healthcare Products (NASDAQ:AHPI) +27%. Exagen (NASDAQ:XGN) +26%. IMV (NASDAQ:IMV) +23%. Arcturus Therapeutics (NASDAQ:ARCT) +21%. Orphazyme A/S...

Arcturus Therapeutics Holdings Inc. (ARCT) Q2 2021 Earnings Conference Call August 09, 2021, 04:30 PM ET Company Participants Neda Safarzadeh - Head of Investor Relations, Public Relations and Marketing Joseph Payne - President and Chief Executive Officer Andy Sassine - Chief Financial Office...

ARCT-021, Arcturus’ single shot STARR™ mRNA COVID vaccine, to begin multinational placebo-controlled Phase 3 efficacy study funded and sponsored by a global entity ARCT-154, Arcturus’ STARR™ mRNA vaccine candidate targeting COVID variants of concern...

Do You Have These Top Health Care Stocks On Your Watchlist This Month? There have been mixed sentiments over the broader stock market over the past month. While many stocks are trading near record-high levels, there are also rising fears of the impact of the fast-spreading delta...

Gainers: BeyondSpring (NASDAQ:BYSI) +151%, Cerus (NASDAQ:CERS) +21%, Novavax (NASDAQ:NVAX) +18%, Global Blood Therapeutics (NASDAQ:GBT) +17%, SCWorx (NASDAQ:WORX) +14%. Losers: Flora Growth (NASDAQ:FLGC) -25%, Arcturus Therapeutics (NASDA...

Gainers: Wilhelmina International (NASDAQ:WHLM) +90%. Arcturus Therapeutics Holdings (NASDAQ:ARCT) +29%. Translate Bio (NASDAQ:TBIO) +29%. Hollysys Automation (NASDAQ:HOLI) +26%. Lava Therapeutics B.V. (NASDAQ:LVTX) +24%. Flora Growth Corp. (NASDAQ:FLGC) +23%. Harmonic (NASDAQ:HLIT) +18%. Uni...

Shares of Arcturus Therapeutics (NASDAQ: ARCT) were soaring 34.7% higher as of 10:56 a.m. EDT on Tuesday. The big jump came after the company announced that Singapore regulators approved the advancement of two messenger RNA COVID-19 vaccine candidates into phase 1/2 clinical testing...